Abraham Chachoua, MD

Abraham Chachoua, MD, associate professor of Oncology, NYU Langone Medical Center, talks about the present use of anti-PD-1 and anti-PD-L1 becoming the standard second-line treatment in lung cancer.

Abraham Chachoua, MD, discusses some challenges of treating patients with lung cancer.